Logo

Fisher Scientific to Acquire Perbio in Move Toward Proteomics

Jun 26, 2003

NEW YORK, June 26 - Fisher Scientific has moved to acquire Swedish reagent supplier Perbio in a move toward proteomics, the companies said today.

 

Fisher, headquartered in Hampton, N.H., will make a $714 million cash offer for all outstanding Perbio shares and warrants on the Stockholm Stock Exchange, and said it has unanimous support from Perbio's board of directors.

 

Perbio supplies consumables for protein research and drug production.

 

"Fisher is one of the most respected names in the life science community, and our focus on proteins has positioned Perbio right at the heart of the biotech revolution," said Mats Fischier, Chairman of Perbio, in a statement.

Breaking News
The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.